TY 2022 Form 990 Schedule J

(A) Name and Title		(B) Breakdown of W-2, 1099-MISC compensation, and/or 1099-NEC			(C) Retirement and other deferred compensation	(D) Nontaxable benefits	(E) Total of columns (B)(i)-(D)	(F) Compensation in column (B) reported as deferred on prior Form 990
(A) Name and Title		(i) Base compensation	(ii) Bonus & incentive compensation	(iii) Other reportable compensation	(C) Retirement and other deferred compensation	(D) Nontaxable benefits	(E) Total of columns (B)(i)-(D)
1Patricia M Currie Former Officer	(i) (ii)	0 ------------- 828,823	0 ------------- 1,468,525	0 ------------- 1,019,086	0 ------------- 15,250	0 ------------- 22,716	0 ------------- 3,354,400	0 ------------- 226,252
2William L Rayburn MD SVP CMO (thru 6/19/2023)	(i) (ii)	0 ------------- 498,763	0 ------------- 200,994	0 ------------- 726,016	0 ------------- 15,250	0 ------------- 23,036	0 ------------- 1,464,059	0 ------------- 618,218
3Lisa L Havens Secretary	(i) (ii)	0 ------------- 568,330	0 ------------- 367,802	0 ------------- 39,137	0 ------------- 193,122	0 ------------- 16,095	0 ------------- 1,184,486	0 ------------- 0
4Jason Jennings President/CEO	(i) (ii)	469,537 ------------- 0	390,598 ------------- 0	32,983 ------------- 0	186,955 ------------- 0	27,277 ------------- 0	1,107,350 ------------- 0	89,900 ------------- 0
5Mark Montgomery MD Trustee	(i) (ii)	0 ------------- 738,791	0 ------------- 61,059	0 ------------- 82,230	0 ------------- 24,400	0 ------------- 26,802	0 ------------- 933,282	0 ------------- 47,509
6Arundhati Rao MD PhD Trustee	(i) (ii)	0 ------------- 549,439	0 ------------- 221,046	0 ------------- 43,048	0 ------------- 78,111	0 ------------- 13,661	0 ------------- 905,305	0 ------------- 0
7Robin W Watson MD Trustee	(i) (ii)	0 ------------- 568,552	0 ------------- 203,285	0 ------------- 4,002	0 ------------- 86,770	0 ------------- 31,010	0 ------------- 893,619	0 ------------- 0
8Angel Caldera MD Trustee	(i) (ii)	0 ------------- 661,002	0 ------------- 1,552	0 ------------- 22,276	0 ------------- 24,400	0 ------------- 26,831	0 ------------- 736,061	0 ------------- 0
9Erin Bird MD Trustee (thru 6/2/2023)	(i) (ii)	0 ------------- 565,002	0 ------------- 37,602	0 ------------- 23,188	0 ------------- 24,400	0 ------------- 29,500	0 ------------- 679,692	0 ------------- 0
10Tresa McNeal MD Trustee	(i) (ii)	0 ------------- 464,567	0 ------------- 35,784	0 ------------- 757	0 ------------- 24,400	0 ------------- 16,631	0 ------------- 542,139	0 ------------- 0
11Dominic Lucia MD Trustee	(i) (ii)	0 ------------- 445,899	0 ------------- 29,263	0 ------------- 722	0 ------------- 24,400	0 ------------- 27,463	0 ------------- 527,747	0 ------------- 0
12Mark English MD Trustee	(i) (ii)	0 ------------- 335,961	0 ------------- 18,733	0 ------------- 61,078	0 ------------- 19,805	0 ------------- 28,989	0 ------------- 464,566	0 ------------- 49,893
13Noe Gutierrez VP CFO	(i) (ii)	232,022 ------------- 0	23,373 ------------- 0	77,369 ------------- 0	12,032 ------------- 0	21,403 ------------- 0	366,199 ------------- 0	0 ------------- 0
14Amber Reed VP CNO	(i) (ii)	87,904 ------------- 147,524	0 ------------- 61,838	128 ------------- 774	2,704 ------------- 20,308	3,855 ------------- 11,426	94,591 ------------- 241,870	0 ------------- 0
15Linda S Clark VP COO Clinic Operations	(i) (ii)	238,964 ------------- 0	58,400 ------------- 0	1,025 ------------- 0	12,392 ------------- 0	20,278 ------------- 0	331,059 ------------- 0	0 ------------- 0
16Geoffrey Christian VP COO	(i) (ii)	233,997 ------------- 0	56,593 ------------- 0	209 ------------- 0	12,134 ------------- 0	20,208 ------------- 0	323,141 ------------- 0	0 ------------- 0
17Rachel Crowder Director Pharmacy	(i) (ii)	179,860 ------------- 0	34,832 ------------- 0	169 ------------- 0	9,511 ------------- 0	19,556 ------------- 0	243,928 ------------- 0	0 ------------- 0
18Brenda Williams RN	(i) (ii)	193,625 ------------- 0	13,903 ------------- 0	6,908 ------------- 0	5,660 ------------- 0	10,785 ------------- 0	230,881 ------------- 0	0 ------------- 0
19Lori Blinka Director Operations	(i) (ii)	154,272 ------------- 0	30,937 ------------- 0	949 ------------- 0	8,237 ------------- 0	26,177 ------------- 0	220,572 ------------- 0	0 ------------- 0
20Sharon Stiles King VP Patient Care	(i) (ii)	26,917 ------------- 126,888	5,000 ------------- 36,199	50 ------------- 248	831 ------------- 7,071	1,882 ------------- 8,053	34,680 ------------- 178,459	0 ------------- 0
21Heather Jordan VP HRSBS	(i) (ii)	161,947 ------------- 0	28,897 ------------- 0	322 ------------- 0	8,321 ------------- 0	10,186 ------------- 0	209,673 ------------- 0	0 ------------- 0

Schedule J (Form 990) 2022

Page 3

Part III

Supplemental Information

Provide the information, explanation, or descriptions required for Part I, lines 1a, 1b, 3, 4a, 4b, 4c, 5a, 5b, 6a, 6b, 7, and 8, and for Part II. Also complete this part for any additional information.

Return Reference	Explanation
Part I, Line 1a	Tax indemnification and gross-up payments-The organization provides tax indemnification where the BSW Holdings' CEO, COO or CFO determines there is justification to reimburse an individual for the tax impact on certain taxable, non-cash benefits provided to them. All tax indemnification payments provided are treated as taxable compensation. Three of the persons listed in the Form 990, Part VII, Section A, received this benefit during the tax year. Discretionary spending account-The organization provides eligible employees who travel frequently in their personal vehicle an auto expense allowance in lieu of reimbursement for business mileage under the organization's business travel and expense reimbursement policy. All auto expense allowances are treated as taxable compensation. One person listed in the Form 990, Part VII, Section A, received this benefit during the tax year. Housing allowance or residence for personal use-The organization provides temporary housing to eligible employees under the organization's moving and relocation reimbursement policy. All temporary housing provided to any employee is treated as taxable compensation. One person listed in the Form 990, Part VII, Section A, received this benefit during the tax year.
Part I, Line 3	Process for determining compensation: The organization, a controlled affiliate of Baylor Scott & White Holdings, recognizes that those chosen to lead the organization are vital to its ongoing success and growth. Thus, it must attract, retain and engage the highest quality officers and key employees to lead the organization and help the organization maintain its national reputation for achieving high targets for medical quality, patient safety, and patient satisfaction. A significant portion of the organization's officers and key employees' total compensation is based on significant performance achievements. This strategy places a greater emphasis on the importance of the organization achieving targeted improvements in the areas of people, quality, patient satisfaction and financial stewardship, annually. Total executive compensation is part of an integrated talent management strategy developed by the Baylor Scott & White Holdings Board of Trustees and its Compensation Committee to attract, motivate, and retain the best leadership resources for the organization. Executive compensation is determined pursuant to guidelines outlined in the intermediate sanction rules under IRC Section 4958 including taking steps to meet the rebuttable presumption standard of reasonableness under Treasury Regulation 53.4958-6, as summarized below. When making compensation decisions, the organization compares itself to similarly-sized, and structured businesses including other integrated health care service systems and other similarly-sized organizations, both locally and nationally. Each year the Baylor Scott & White Holdings Board of Trustees and the Compensation Committee, on behalf of the organization through reserved powers explicitly held by Baylor Scott & White Holdings, works directly with an independent compensation consultant(s) to identify reasonable and competitive market rates as well as provide an annual review of the total compensation of the organization's top management officials and other officers and key employees to ensure total compensation is within a fair market range. The annual review included reviewing certain officers and key employees listed on the Form 990 during the current tax year. The Compensation Committee is made up of members of the Baylor Scott & White Holdings Board of Trustees, who are independent, community volunteers. Guided by the information provided by the independent compensation consultant(s), the Compensation Committee approves the annual process and methodology for setting fair market salary ranges, earned incentives, and/or benefit offerings for the organization's President, other officers and/or key employees to be comparable to similar organizations for similar services and/or positions. Furthermore, the Compensation Committee is charged with the responsibility of reviewing annually the major elements of the executive compensation program to assure designs remain consistent with the business needs, market practices, and compensation philosophy. As part of the decision-making process, the Compensation Committee will often meet in executive session to discuss and review recommendations made by the independent compensation consultant(s). No officer or key employee whose compensation is being reviewed is present during these discussions. All decisions are properly documented in the minutes of the meetings.
Part I, Line 4b	In order to recruit and retain key talent, BSW Holdings and certain tax exempt affiliates (BSWH) offers a supplemental non-qualified retirement plan to eligible employees. The plan provides an annual benefit (based on a percentage of compensation) to the employee that is paid to the employee on a future date upon vesting in the plan. The following individual(s) participated in and/or received payments (noted in parenthesis) from BSWH's supplemental non-qualified retirement plan during the tax year: Amber Reed, Angel Caldera, M.D., Arundhati Rao, M.D., Ph.D., Dominic Lucia, M.D., Erin Bird, M.D., Jason Jennings, Lisa L. Havens, Mark English, M.D. ($54,130), Mark Montgomery, M.D. ($56,040), Patricia M. Currie, Robin W. Watson, M.D., Tresa McNeal, M.D. and William L. Rayburn, M.D.
Part I, Line 7	The organization has adopted and implemented BSW Holdings', the organization's ultimate parent, Annual Incentive Program to provide a market competitive total cash compensation incentive program that is designed to attract and retain key leaders and establish greater individual accountability and alignment to business performance. Payout targets are based upon a percentage of base pay and are developed by independent third party expert(s) using comparable market competitive data within the bounds of reasonableness and that are reviewed and approved by BSW Holdings' governing body. Payout levels are based upon a combination of system, entity, and individual performance using various metrics related to quality, patient satisfaction, employee retention, and financial stewardship. BSW Holdings' governing body may approve modifications to annual incentive awards provided under the program consistent with market comparability data.
Form 990, Schedule J, Part III	Supplemental Information: Governing Body Compensation The members of the governing body serve on a voluntary basis and receive no cash compensation from the organization for these duties as a member of the governing body. Some, but not all, members may have received modest benefits incident to their service on the board and/or multiple board committees or received compensation as an employee of a related organization. All such benefits are treated as taxable compensation to the extent required by law and are reported in the Form 990 where applicable.

Software ID:
Software Version: